Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)

Clinical trial NCT04421664 · TERMINATED

Trial details

NCT number: NCT04421664
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Corona Virus Infection SARS-CoV Infection Coronavirus

Start date: 2020-03-25
Primary completion: 2020-08-17
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.